ArticleCureus2026
A Retrospective Observational Study on the Eleganza Protocol: A Standardized Seven-Step Workflow for Combined Aesthetic Surgery.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Combined aesthetic surgery ("mommy makeover") is increasingly performed to address postpartum body contour deformities; however, prolonged operative time remains associated with increased perioperative morbidity. The Eleganza Protocol was developed as a standardized workflow-oriented approach designed to optimize operative sequencing and operative efficiency during combined aesthetic surgery. Methods A retrospective observational study was conducted including 13 consecutive patients treated at two independent surgical centers using the Eleganza Protocol. The protocol consists of a predefined seven-step operative sequence integrating coordinated team-based execution, neuraxial anesthesia, and an anterior-to-posterior surgical workflow. Combined procedures included mastopexy, breast augmentation, abdominoplasty, and extensive liposuction. Primary outcomes were operative time and 30-day postoperative complications classified according to the Clavien-Dindo system. Secondary outcomes included estimated blood loss and intraoperative transfusion requirements. Results Most procedures were completed within four hours, with nine of 13 patients (69.2%) finishing within this threshold (median operative time: 3.5 hours; q25-q75: 3.0-4.5). The median estimated blood loss was 250 mL (q25-q75: 100-300 mL), and no intraoperative transfusions were required. No major postoperative complications (Clavien-Dindo grade ≥II) occurred during the 30-day follow-up period. Minor self-limited complications included transient edema and ecchymosis. No patient required prolonged hospitalization beyond the planned overnight stay. Conclusions This retrospective observational study describes operative performance and short-term safety in consecutive patients undergoing combined aesthetic surgery using the Eleganza Protocol. Operative times remained within a consistent range despite procedural variability, with low estimated blood loss and no major short-term postoperative complications. Further prospective multicenter studies are warranted to evaluate reproducibility, operative performance, safety, and long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.